Monitoring changes in metabolic pathways
Monday 22 May, 2017, 12:30-13:30 in Room G3
Nick Howe, Agilent Technologies – Product Specialist, Seahorse XF Consumables
Lasse Martlev, Agilent Technologies – Product Specialist, Seahorse XF Instruments
The unique metabolic properties and liabilities of age-related diseases are leading to many fresh perspectives of how to intervene in chronic, progressive disorders. A growing body of evidence points to a primary role for metabolism in age-related diseases.
Agilent Seahorse XF Extracellular Flux Analyzers measure cell metabolism, simultaneously measuring the two major energy-producing pathways within the cell - mitochondrial respiration and glycolysis - in live cells, in real time.
The acceptance of Agilent Seahorse XF Analyzers as the industry standard for measuring cell metabolism is evident in the increasing rate of scientific publications that contain references to XF data. Using XF technology researchers can now more easily study cell metabolism and mitochondrial dysfunction and gain greater understanding about disease progression, impacting research in age-related diseases, such as cancer, diabetes, Alzheimer's, Parkinson's, Huntington's, and cardiovascular disease.
In this XF technology workshop you will learn:
- How XF technology measures both respiration and glycolysis in live cells
- How to conduct simple and powerful XF stresstests
- How XF data is being used to further age-related research with real world examples
« Go Back